{"id":964144,"date":"2026-05-18T11:03:26","date_gmt":"2026-05-18T15:03:26","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/philips-highlights-advances-in-imaging-and-physiology-to-support-complex-pci-at-europcr-2026\/"},"modified":"2026-05-18T11:03:26","modified_gmt":"2026-05-18T15:03:26","slug":"philips-highlights-advances-in-imaging-and-physiology-to-support-complex-pci-at-europcr-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/philips-highlights-advances-in-imaging-and-physiology-to-support-complex-pci-at-europcr-2026\/","title":{"rendered":"Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026"},"content":{"rendered":"
\n

May 18, 2026<\/p>\n

\n From imaging to AI-enabled guidance, Philips connects technologies into a unified workflow to improve efficiency, reduce radiation exposure and support procedural confidence
<\/i>
\n
\n
Amsterdam, the Netherlands \u2013<\/b> As cardiac procedures become more complex, interventional cardiologists must balance the need for precise imaging and decision-making with growing pressure to reduce radiation exposure for both patients and staff. At EuroPCR 2026<\/a> in Paris (May 19\u201322), Royal Philips<\/a> (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase how advances in imaging, physiology and real-time guidance can help clinicians manage complexity while supporting safer, lower-dose procedures.<\/p>\n

At this year\u2019s Philips booth, visitors can explore an immersive experience designed to reflect clinical decision-making during complex procedures. Through guided demonstrations and educational sessions, clinicians can see and experience how imaging, physiology, AI-enabled guidance and dose management technologies come together to support each step of the intervention.<\/p>\n

In today\u2019s PCI and structural heart procedures, clinicians often rely on multiple imaging systems and tools to guide decisions in real time. Combining angiography, intravascular imaging, physiology and device positioning \u2013 while coordinating across the care team \u2013 can make procedures more complex and time-sensitive. At the same time, cumulative radiation exposure remains a key concern, with clinical communities emphasizing the importance of keeping exposure \u201cas low as reasonably achievable (ALARA).\u201d<\/p>\n

Integration and dose management<\/b>
Philips\u2019 approach focuses on addressing both challenges through integration and dose management. By bringing imaging, physiology and procedural guidance together into a unified workflow, clinicians can work from a more complete view of the patient and procedure. At the same time, imaging innovations are designed to reduce radiation exposure at the source \u2013 without compromising image quality or clinical confidence.<\/p>\n

At EuroPCR 2026, Philips will introduce and showcase a range of innovations that reflect this approach, including:<\/p>\n